Published in Circ Res on July 01, 1993
Identification and characterization of a fibroblast marker: FSP1. J Cell Biol (1995) 6.33
PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol (1998) 5.21
Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol (1996) 2.88
A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages. Mol Cell Biol (1997) 2.20
High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest (1994) 2.13
Analysis of SM22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol Cell Biol (2001) 1.74
Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol (1999) 1.28
New insights into the regulation of the actin cytoskeleton by tropomyosin. Int Rev Cell Mol Biol (2010) 1.28
Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. J Clin Invest (1995) 1.23
Direct effects of phosphate on vascular cell function. Adv Chronic Kidney Dis (2011) 1.17
Nesprins: from the nuclear envelope and beyond. Expert Rev Mol Med (2013) 1.15
Smooth muscle alternative splicing induced in fibroblasts by heterologous expression of a regulatory gene. EMBO J (1996) 1.15
Conserved phosphorylation of serines in the Ser-X-Glu/Ser(P) sequences of the vitamin K-dependent matrix Gla protein from shark, lamb, rat, cow, and human. Protein Sci (1994) 1.07
Differentiated vascular myocytes: are they involved in neointimal formation? J Clin Invest (1996) 1.04
Mechanisms and clinical consequences of vascular calcification. Front Endocrinol (Lausanne) (2012) 1.01
Caldesmon and the regulation of cytoskeletal functions. Adv Exp Med Biol (2008) 0.98
Human gene expression sensitivity according to large scale meta-analysis. BMC Bioinformatics (2009) 0.95
Cloning and analysis of the promoter region of the rat SM22 alpha gene. Biochem J (1995) 0.95
Cellular retinol-binding protein-1 is expressed by distinct subsets of rat arterial smooth muscle cells in vitro and in vivo. Am J Pathol (1997) 0.94
Nesprins: tissue-specific expression of epsilon and other short isoforms. PLoS One (2014) 0.92
The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells. Nat Commun (2012) 0.92
Phenotypic modulation of primary vascular smooth muscle cells by short-term culture on micropatterned substrate. PLoS One (2014) 0.91
Evidence for a calcification process in the trabecular meshwork. Exp Eye Res (2008) 0.91
Human red cell Aquaporin CHIP. II. Expression during normal fetal development and in a novel form of congenital dyserythropoietic anemia. J Clin Invest (1994) 0.90
Small intestinal submucosa seeded with intestinal smooth muscle cells in a rodent jejunal interposition model. J Surg Res (2011) 0.88
Vascular calcification and renal bone disorders. ScientificWorldJournal (2014) 0.88
Identification of a novel negative retinoic acid responsive element in the promoter of the human matrix Gla protein gene. Proc Natl Acad Sci U S A (1997) 0.86
Selective modulation of the SM22alpha promoter by the binding of BTEB3 (basal transcription element-binding protein 3) to TGGG repeats. Biochem J (2003) 0.85
Tissue engineering in the gut: developments in neuromusculature. Gastroenterology (2014) 0.85
Expression of an acidic isoform of calponin in rat brain: western blots on one- or two-dimensional gels and immunolocalization in cultured cells. Biochem J (1995) 0.84
Functional expression of smooth muscle-specific ion channels in TGF-β(1)-treated human adipose-derived mesenchymal stem cells. Am J Physiol Cell Physiol (2013) 0.84
Linker of nucleoskeleton and cytoskeleton complex proteins in cardiac structure, function, and disease. Circ Res (2014) 0.83
Panax notoginseng Saponins Attenuate Phenotype Switching of Vascular Smooth Muscle Cells Induced by Notch3 Silencing. Evid Based Complement Alternat Med (2015) 0.82
Association between the hypomethylation of osteopontin and integrin β3 promoters and vascular smooth muscle cell phenotype switching in great saphenous varicose veins. Int J Mol Sci (2014) 0.81
Induction of aquaporin-1 mRNA following cardiopulmonary bypass and reperfusion. Mol Med (1997) 0.81
Attenuation of chondrogenic transformation in vascular smooth muscle by dietary quercetin in the MGP-deficient mouse model. PLoS One (2013) 0.81
Mapping of the rat SM22 gene to chromosome 8q24: a candidate for high blood pressure and cardiac hypertrophy. Mamm Genome (1998) 0.78
Disruption of canonical TGFβ-signaling in murine coronary progenitor cells by low level arsenic. Toxicol Appl Pharmacol (2013) 0.78
Protein expression profile using two-dimensional gel analysis in squamous cervical cancer patients. Cancer Res Treat (2006) 0.78
Sturgeon osteocalcin shares structural features with matrix Gla protein: evolutionary relationship and functional implications. J Biol Chem (2013) 0.77
Two sides of MGP null arterial disease: chondrogenic lesions dependent on transglutaminase 2 and elastin fragmentation associated with induction of adipsin. J Biol Chem (2013) 0.77
Basic fibroblast growth factor as a selective inducer of matrix Gla protein gene expression in proliferative chondrocytes. Biochem J (2003) 0.77
Calcifying nanoparticles promote mineralization in vascular smooth muscle cells: implications for atherosclerosis. Int J Nanomedicine (2014) 0.76
Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells. Exp Mol Med (2012) 0.76
Superparamagnetic iron oxide nanoparticles regulate smooth muscle cell phenotype. J Biomed Mater Res A (2016) 0.75
Bidirectional Translation in Cardiovascular Calcification. Arterioscler Thromb Vasc Biol (2016) 0.75
Critical Parameters of the In Vitro Method of Vascular Smooth Muscle Cell Calcification. PLoS One (2015) 0.75
POSVP(21), a major secretory androgen-dependent protein from sand rat seminal vesicles, identified as a transgelin. Asian J Androl (2010) 0.75
Short-term vasculoprotective effects of imatinib mesylate on intimal hyperplasia of arterial anastomosis: An experimental study using a rabbit model. Can J Plast Surg (2012) 0.75
Effects of donor age and proliferative aging on the phenotype stability of rat aortic smooth muscle cells. Physiol Rep (2015) 0.75
Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation (2002) 4.43
Free cytoplasmic calcium concentration and the mitogenic stimulation of lymphocytes. J Biol Chem (1983) 3.44
Nesprins: a novel family of spectrin-repeat-containing proteins that localize to the nuclear membrane in multiple tissues. J Cell Sci (2001) 3.24
Reconstitution of a calcium pump using defined membrane components. Proc Natl Acad Sci U S A (1974) 3.11
Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet (1999) 3.08
Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation (1999) 2.95
Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond) (1998) 2.68
The mechanism of the calcium signal and correlation with histamine release in 2H3 cells. J Biol Chem (1984) 2.58
A common sequence of calcium and pH signals in the mitogenic stimulation of eukaryotic cells. Nature (1985) 2.53
Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res (2000) 2.50
The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med (1995) 2.42
Cholesterol is excluded from the phospholipid annulus surrounding an active calcium transport protein. Nature (1975) 2.30
The calcium signal and phosphatidylinositol breakdown in 2H3 cells. J Biol Chem (1984) 2.19
Mitogens increase phosphorylation of phosphoinositides in thymocytes. Nature (1985) 2.18
The proton relaxation of benzyl alcohol in erythrocyte membranes. Mol Pharmacol (1968) 2.17
High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest (1994) 2.13
The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it. Biochim Biophys Acta (1976) 2.07
Annular lipids determine the ATPase activity of a calcium transport protein complexed with dipalmitoyllecithin. Biochemistry (1976) 2.06
Cap formation by various ligands on lymphocytes shows the same dependence on high cellular ATP levels. Biochim Biophys Acta (1980) 2.03
Is an early calcium flux necessary to stimulate lymphocytes? Nature (1977) 2.03
Tamoxifen elevates transforming growth factor-beta and suppresses diet-induced formation of lipid lesions in mouse aorta. Nat Med (1995) 1.88
Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice. Nature (1994) 1.87
13 C nuclear magnetic resonance relaxation measurements of synthetic lecithins and the effect of spin-labeled lipids. Biochemistry (1972) 1.83
Intracellular calcium measurements by 19F NMR of fluorine-labeled chelators. Proc Natl Acad Sci U S A (1983) 1.77
Reversible lipid titrations of the activity of pure adenosine triphosphatase-lipid complexes. Biochemistry (1974) 1.73
Degenerate perturbations of protein structure as the mechanism of anaesthetic action. Nature (1979) 1.68
Streptokinase resistance: when might streptokinase administration be ineffective? Br Heart J (1992) 1.66
A calcium hypothesis for the control of cell growth. Biochem Soc Symp (1980) 1.66
Sensitivity to Fas-mediated apoptosis is determined below receptor level in human vascular smooth muscle cells. Circ Res (2000) 1.53
Intracellular pH of stimulated thymocytes measured with a new fluorescent indicator. J Biol Chem (1983) 1.53
Triggering of lymphocyte capping appears not to require changes in potential or ion fluxes across the plasma membrane. Biochim Biophys Acta (1980) 1.52
Clusters in lipid bilayers and the interpretation of thermal effects in biological membranes. Biochemistry (1974) 1.50
Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med (2006) 1.49
The interaction of paramagnetic ions and spin labels with lecithin bilayers. Biochim Biophys Acta (1973) 1.49
Exchange of partners in glucagon receptor-adenylate cyclase complexes. Physical evidence for the independent, mobile receptor model. Biochim Biophys Acta (1977) 1.46
TGF-beta in blood: a complex problem. Cytokine Growth Factor Rev (2000) 1.40
Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science (1993) 1.40
Biological responses to electromagnetic fields. FASEB J (1998) 1.39
Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost (2007) 1.38
The interaction of small molecules with spin-labelled erythrocyte membranes. Biochim Biophys Acta (1970) 1.35
Free cytosolic Ca2+ measurements with fluorine labelled indicators using 19FNMR. Cell Calcium (1985) 1.34
The lipid environment of the glucagon receptor regulates adenylate cyclase activity. Biochim Biophys Acta (1976) 1.34
Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med (1995) 1.31
Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions. Arterioscler Thromb Vasc Biol (2001) 1.26
The effect of bilayer thickness on the activity of (Na+ + K+)-ATPase. Biochim Biophys Acta (1981) 1.26
Targeting tumour vasculature: the development of combretastatin A4. Lancet Oncol (2001) 1.25
c-fos and c-myc gene activation, ionic signals, and DNA synthesis in thymocytes. J Biol Chem (1986) 1.24
13 C and 1 H nuclear magnetic resonance relaxation measurements of the lipids of sarcoplasmic reticulum membranes. Biochemistry (1972) 1.23
Relaxation of anaesthetics in the presence of cyto-membranes. Nature (1968) 1.19
Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol (1998) 1.19
A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels. J Biol Chem (2001) 1.19
Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Biol (1998) 1.18
Intracellular pH and free calcium changes in single cells using quene 1 and quin 2 probes and fluorescence microscopy. FEBS Lett (1983) 1.17
Calcium regulates inositol 1,3,4,5-tetrakisphosphate production in lysed thymocytes and in intact cells stimulated with concanavalin A. EMBO J (1987) 1.16
Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. Arterioscler Thromb Vasc Biol (2000) 1.16
Identification of osteoglycin as a component of the vascular matrix. Differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques. Arterioscler Thromb Vasc Biol (1997) 1.15
Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol (2001) 1.15
The role of Gla proteins in vascular calcification. Crit Rev Eukaryot Gene Expr (1998) 1.14
High resolution proton relaxation studies of lecithins. Biochim Biophys Acta (1972) 1.13
Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer. Cancer Res (2001) 1.13
Mitogenic stimulation and the redistribution of concanavalin A receptors on lymphocytes. Exp Cell Res (1981) 1.12
Transient complexes. A new structural model for the activation of adenylate cyclase by hormone receptors (guanine nucleotides/irradiation inactivation). Biochem J (1979) 1.11
The effect of bilayer thickness and n-alkanes on the activity of the (Ca2+ + Mg2+)-dependent ATPase of sarcoplasmic reticulum. J Biol Chem (1981) 1.09
The role of apoptosis in the initiation of vascular calcification. Z Kardiol (2001) 1.08
Dietary fat and reduced levels of TGFbeta1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions. J Cell Sci (2000) 1.07
Ca2+ transient, Mg2+, and pH measurements in the cardiac cycle by 19F NMR. Proc Natl Acad Sci U S A (1988) 1.06
Changes in free-calcium levels and pH in synaptosomes during transmitter release. Biochim Biophys Acta (1984) 1.06
Measurement of fast lateral diffusion of lipids in vesicles and in biological membranes by 1 H nuclear magnetic resonance. Biochemistry (1973) 1.06
A large accumulation of non-muscle myosin occurs at first entry into M phase in rat vascular smooth-muscle cells. Biochem J (1991) 1.06
Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation (2002) 1.06
Mouse BTEB3, a new member of the basic transcription element binding protein (BTEB) family, activates expression from GC-rich minimal promoter regions. Biochem J (2000) 1.05
Mechanisms of pHi recovery after global ischemia in the perfused heart. Circ Res (1993) 1.04
Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis. J Pathol (2000) 1.04
Calcium signals and phospholipid methylation in eukaryotic cells. Biochem J (1984) 1.04
Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res (1998) 1.03
Synergistic signals in the mechanism of antigen-induced exocytosis in 2H3 cells: evidence for an unidentified signal required for histamine release. J Cell Biol (1987) 1.01
Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling. Circ Res (2001) 1.01
The Id gene is activated by serum but is not required for de-differentiation in rat vascular smooth muscle cells. Biochem J (1991) 1.01
Early increases in phospholipid methylation are not necessary for the mitogenic stimulation of lymphocytes. J Biol Chem (1982) 1.00
Ca2+ and pH responses to sequential additions of mitogens in single 3T3 fibroblasts: correlations with DNA synthesis. J Biol Chem (1988) 1.00
Four isoforms of serum response factor that increase or inhibit smooth-muscle-specific promoter activity. Biochem J (2000) 0.99
Lipid phase transitions control beta-hydroxybutyrate dehydrogenase activity in defined-lipid protein complexes. FEBS Lett (1975) 0.99
Transforming growth factor-beta dynamically regulates vascular smooth muscle differentiation in vivo. J Cell Sci (1998) 0.99
Some mitogens cause rapid increases in free calcium in fibroblasts. FEBS Lett (1984) 0.98
Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. Circ Res (1997) 0.98
Methyl-cellulose paint possibly causing heart failure. Br Med J (1979) 0.98
The exogenous lipid requirement for histamine release from rat peritoneal mast cells stimulated by concanavalin A. FEBS Lett (1979) 0.98
A regulatory element downstream of the rat SM22 alpha gene transcription start point enhances reporter gene expression in vascular smooth muscle cells. Gene (1995) 0.97
High adenoviral loads stimulate NF kappaB-dependent gene expression in human vascular smooth muscle cells. Gene Ther (1998) 0.97
13C-enriched phosphatidylethanolamines from Escherichia coli. Biochim Biophys Acta (1975) 0.96
Cloning and analysis of the promoter region of the rat SM22 alpha gene. Biochem J (1995) 0.95
Active and acid-activatable TGF-beta in human sera, platelets and plasma. Clin Chim Acta (1995) 0.95
A determination of the mobility gradient in lipid bilayers by 13C nuclear magnetic resonance. Proc R Soc Lond B Biol Sci (1976) 0.95